The doctor says more patients have been coming in over recent years after losing a lot of weight on drugs like Ozempic and Mounjaro.
Recap by typeshit. Post by @somenekmd on Instagram.
A short Facebook share with no context on who used the peptides, where it happened or what followed.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
2:07:50
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
Dr. Nadolsky responds to the common line that people should just eat less and move more instead of taking Ozempic.
For some people on GLP-1 drugs, losing weight opens up clothing options they didn't have before, and with them new ways to express identity.
Loading…